UC awarded 12th patent for CRISPR-Cas9 gene-editing technology
Lianne Frick/File
The UC system and partners University of Vienna and Emmanuelle Charpentier were awarded a 12th patent for the CRISPR-Cas9 gene-editing technology.
Read More…
UC becomes largest CRISPR-Cas9 patent portfolio holder
The UC system was awarded a patent Tuesday, marking the university’s 16th patent for the CRISPR-Cas9 patent portfolio — the highest number in the country.
Read More…
UC system awarded 9th, 10th patents for CRISPR gene-editing technology
By the end of the summer, the UC system expects to receive five more patents, raising its portfolio to 15 total patents related to CRISPR technology.
Read More…
UC obtains 8th patent for CRISPR gene-editing methods
The UC’s family of eight patents covers CRISPR methods for editing genes in any environment, whether the cells are in a plant, an animal or a human. This newest patent focuses specifically on the use of CRISPR gene editing within cells.
Read More…
Patent board announces interference between UC, Broad Institute CRISPR patents
The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office announced an interference between multiple UC and multiple Broad Institute patents, a signal that the USPTO will resolve the seven-year ownership debate regarding CRISPR-Cas9 genome editing in eukaryotic cells.
Read More…
UC receives 5th patent for CRISPR-Cas9 gene-editing system
The U.S. Patent and Trademark Office granted the University of California a new patent for the revolutionary CRISPR-Cas9 system of gene-editing technology on Tuesday. The patent, No. 10,301,651, covers methods of modulating DNA transcription.
Read More…
UC Berkeley receives its 4th CRISPR patent, expects 3 more after
On April 23, the U.S. Patent and Trademark Office issued UC Berkeley its fourth patent for CRISPR Cas-9, a revolutionary gene-editing technology.
Read More…
UC receives 3rd CRISPR patent after 4 years of litigation
After four years of litigation battles, the US Patent and Trademark Office, or USPTO, has finally approved a third CRISPR patent for the University of California.
Read More…
UC files opening brief to appeal CRISPR-Cas9 patent decision
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board (PTAB) which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
Read More…
China will grant CRISPR patent to UC
China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology.
Read More…
